You cannot apply for this job anymore.
Browse the current job offer or choose an item in the top navigation above.
Sanquin Research’s Department of Immunopathology is looking for a highly motivated and ambitious biomedical or biopharmaceutical sciences post-doctoral researcher.
The post-doc position is part of the EU-funded H20202 project ReSToRe. Patients with multiple sclerosis are being treated with peptide-loaded tolerogenic dendritic cells in hospitals in Barcelona and Antwerp. The post-doc here will focus on the analyses of antigen-specific T and B cell responses. The first part of the project will focus on the generation and application of recombinant MHC class II tetramers for detection of antigen-specific CD4 T cells using a novel approach/technology. In the second part of the project we will use several assays to analyze in depth the T and B cell responses in multiple sclerosis patients upon treatment. Single cell RNAseq may be used to study differences between antigen-specific CD4 T and B cells before and after treatment.
The Immune modulation and Immunomonitoring Research group is part of the Department of Immunopathology in the Division Research of Sanquin. We investigate the modulation of immune responses by blood products as well as immunomodulatory therapies, with a specific focus on CD4+ T cell responses. The department comprises 40-50 people (post-docs, PhD-students, undergraduate students and technicians) that all work on related research topics. In this project we closely collaborate with the Division Diagnostics, especially with the Immunomonitoring services, where pre-clinical and clinical testing for Biotech and Pharma is performed.
A unique research opportunity in a dynamic environment in an area where data science, clinical epidemiology and quality management meet.
Curious about this project? Read more about it below the video.
Sanquin Blood Supply Foundation (Sanquin)
Plesmanlaan 125, 1066 CX, Amsterdam